166 related articles for article (PubMed ID: 16099924)
21. Genotoxic mechanism of tamoxifen in developing endometrial cancer.
Kim SY; Suzuki N; Laxmi YR; Shibutani S
Drug Metab Rev; 2004 May; 36(2):199-218. PubMed ID: 15237851
[TBL] [Abstract][Full Text] [Related]
22. Inefficient repair of tamoxifen-DNA adducts in rats and mice.
Kim SY; Suzuki N; Laxmi YR; Shibutani S
Drug Metab Dispos; 2006 Feb; 34(2):311-7. PubMed ID: 16299164
[TBL] [Abstract][Full Text] [Related]
23. Tamoxifen metabolic activation: comparison of DNA adducts formed by microsomal and chemical activation of tamoxifen and 4-hydroxytamoxifen with DNA adducts formed in vivo.
Moorthy B; Sriram P; Pathak DN; Bodell WJ; Randerath K
Cancer Res; 1996 Jan; 56(1):53-7. PubMed ID: 8548775
[TBL] [Abstract][Full Text] [Related]
24. Antiestrogens and the formation of DNA damage in rats: a comparison.
Kim SY; Suzuki N; Laxmi YR; Umemoto A; Matsuda T; Shibutani S
Chem Res Toxicol; 2006 Jun; 19(6):852-8. PubMed ID: 16780365
[TBL] [Abstract][Full Text] [Related]
25. Formation of tamoxifen-DNA adducts in multiple organs of adult female cynomolgus monkeys dosed with tamoxifen for 30 days.
Schild LJ; Divi RL; Beland FA; Churchwell MI; Doerge DR; Gamboa da Costa G; Marques MM; Poirier MC
Cancer Res; 2003 Sep; 63(18):5999-6003. PubMed ID: 14522927
[TBL] [Abstract][Full Text] [Related]
26. Activation of tamoxifen and its metabolite alpha-hydroxytamoxifen to DNA-binding products: comparisons between human, rat and mouse hepatocytes.
Phillips DH; Carmichael PL; Hewer A; Cole KJ; Hardcastle IR; Poon GK; Keogh A; Strain AJ
Carcinogenesis; 1996 Jan; 17(1):89-94. PubMed ID: 8565142
[TBL] [Abstract][Full Text] [Related]
27. Identification of hepatic tamoxifen-DNA adducts in mice: alpha-(N(2)-deoxyguanosinyl)tamoxifen and alpha-(N(2)-deoxyguanosinyl)tamoxifen N-oxide.
Umemoto A; Monden Y; Suwa M; Kanno Y; Suzuki M; Lin CX; Ueyama Y; Momen MA; Ravindernath A; Shibutani S; Komaki K
Carcinogenesis; 2000 Sep; 21(9):1737-44. PubMed ID: 10964106
[TBL] [Abstract][Full Text] [Related]
28. Hepatic DNA adduct dosimetry in rats fed tamoxifen: a comparison of methods.
Schild LJ; Phillips DH; Osborne MR; Hewer A; Beland FA; Churchwell MI; Brown K; Gaskell M; Wright E; Poirier MC
Mutagenesis; 2005 Mar; 20(2):115-24. PubMed ID: 15755801
[TBL] [Abstract][Full Text] [Related]
29. Effects of chronic administration of tamoxifen and toremifene on DNA adducts in rat liver, kidney, and uterus.
Li D; Dragan Y; Jordan VC; Wang M; Pitot HC
Cancer Res; 1997 Apr; 57(8):1438-41. PubMed ID: 9108442
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical localization and semi-quantitation of hepatic tamoxifen-DNA adducts in rats exposed orally to tamoxifen.
Divi RL; Dragan YP; Pitot HC; Poirier MC
Carcinogenesis; 2001 Oct; 22(10):1693-9. PubMed ID: 11577011
[TBL] [Abstract][Full Text] [Related]
31. alpha-Hydroxytamoxifen, a metabolite of tamoxifen with exceptionally high DNA-binding activity in rat hepatocytes.
Phillips DH; Carmichael PL; Hewer A; Cole KJ; Poon GK
Cancer Res; 1994 Nov; 54(21):5518-22. PubMed ID: 7923188
[TBL] [Abstract][Full Text] [Related]
32. Tamoxifen-DNA adduct formation in monkey and human reproductive organs.
Hernandez-Ramon EE; Sandoval NA; John K; Cline JM; Wood CE; Woodward RA; Poirier MC
Carcinogenesis; 2014 May; 35(5):1172-6. PubMed ID: 24501327
[TBL] [Abstract][Full Text] [Related]
33. DNA adducts from nitroreduction of 2,7-dinitrofluorene, a mammary gland carcinogen, catalyzed by rat liver or mammary gland cytosol.
Ritter CL; Culp SJ; Freeman JP; Marques MM; Beland FA; Malejka-Giganti D
Chem Res Toxicol; 2002 Apr; 15(4):536-44. PubMed ID: 11952340
[TBL] [Abstract][Full Text] [Related]
34. Peroxidase-mediated dealkylation of tamoxifen, detected by electrospray ionization-mass spectrometry, and activation to form DNA adducts.
Gaikwad NW; Bodell WJ
Free Radic Biol Med; 2012 Jan; 52(2):340-7. PubMed ID: 22064363
[TBL] [Abstract][Full Text] [Related]
35. Tamoxifen-DNA adducts formed by alpha-acetoxytamoxifen N-oxide.
Umemoto A; Monden Y; Komaki K; Suwa M; Kanno Y; Suzuki M; Lin CX; Ueyama Y; Momen MA; Ravindernath A; Shibutani S
Chem Res Toxicol; 1999 Nov; 12(11):1083-9. PubMed ID: 10563834
[TBL] [Abstract][Full Text] [Related]
36. Effect of long-term tamoxifen exposure on genotoxic and epigenetic changes in rat liver: implications for tamoxifen-induced hepatocarcinogenesis.
Tryndyak VP; Muskhelishvili L; Kovalchuk O; Rodriguez-Juarez R; Montgomery B; Churchwell MI; Ross SA; Beland FA; Pogribny IP
Carcinogenesis; 2006 Aug; 27(8):1713-20. PubMed ID: 16632870
[TBL] [Abstract][Full Text] [Related]
37. Identification and quantification of tamoxifen-DNA adducts in the liver of rats and mice.
Umemoto A; Komaki K; Monden Y; Suwa M; Kanno Y; Kitagawa M; Suzuki M; Lin CX; Ueyama Y; Momen MA; Ravindernath A; Shibutani S
Chem Res Toxicol; 2001 Aug; 14(8):1006-13. PubMed ID: 11511174
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the DNA adducts formed by tamoxifen and 4-hydroxytamoxifen in vivo.
Beland FA; McDaniel LP; Marques MM
Carcinogenesis; 1999 Mar; 20(3):471-7. PubMed ID: 10190564
[TBL] [Abstract][Full Text] [Related]
39. Identification of tamoxifen-DNA adducts formed by alpha-sulfate tamoxifen and alpha-acetoxytamoxifen.
Dasaradhi L; Shibutani S
Chem Res Toxicol; 1997 Feb; 10(2):189-96. PubMed ID: 9049430
[TBL] [Abstract][Full Text] [Related]
40. DNA adduct formation and mutant induction in Sprague-Dawley rats treated with tamoxifen and its derivatives.
Gamboa da Costa G; McDaniel-Hamilton LP; Heflich RH; Marques MM; Beland FA
Carcinogenesis; 2001 Aug; 22(8):1307-15. PubMed ID: 11470763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
